These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11260147)

  • 1. Differential mediator release from basophils of allergic and non-allergic asthmatic patients after stimulation with anti-IgE and C5a.
    Abrahamsen O; Haas H; Schreiber J; Schlaak M
    Clin Exp Allergy; 2001 Mar; 31(3):368-78. PubMed ID: 11260147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
    Kurimoto Y; De Weck AL; Dahinden CA
    Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
    Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
    Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An attempt to block histamine release from basophils granulocytes with antibodies obtained as a result of long-term immunization].
    Szymaniak L
    Ann Acad Med Stetin; 1998; 44():45-64. PubMed ID: 9857531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 3-dependent mediator release in basophils triggered by C5a.
    Kurimoto Y; de Weck AL; Dahinden CA
    J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
    J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive sensitization of basophil leukocytes from non-atopic adult by plasma from allergic children.
    Nolte H; Stafanger G; Skov PS; Schiøtz PO
    Allergy; 1988 Jan; 43(1):32-8. PubMed ID: 2449829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kowal K; Bielecki P; DuBuske IV; DuBuske LM
    Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil degranulation in response to IgE ligation is controlled by a distinctive circadian clock in asthma.
    Spadaro G; Giurato G; Stellato C; Marone G; Casolaro V
    Allergy; 2020 Jan; 75(1):158-168. PubMed ID: 31355941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro basophil histamine-releasing activity of circulating IgG1 and IgG4 autoanti-IgE antibodies from asthma patients and the demonstration that anti-IgE modulates allergen-induced basophil activation.
    Shakib F; Smith SJ
    Clin Exp Allergy; 1994 Mar; 24(3):270-5. PubMed ID: 7516815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive sensitization and histamine release of basophils. IgE and cellular factors regulating histamine release.
    Nolte H; Poulsen M; Schiøtz PO; Skov PS
    Allergy; 1990 Aug; 45(6):427-35. PubMed ID: 1700888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous serum skin test reactivity in patients with non-allergic asthma.
    Tedeschi A; Comi AL; Lorini M; Tosini C; Miadonna A
    Clin Exp Allergy; 2005 Jul; 35(7):849-53. PubMed ID: 16008669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil mediator release in atopic dermatitis.
    Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
    J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polynuclear basophils, the key to allergic reactions. Modulations by chemokines].
    Devouassoux G
    Rev Mal Respir; 2000 Jun; 17(3):629-40. PubMed ID: 10951958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.
    Noga O; Hanf G; Kunkel G; Kleine-Tebbe J
    Int Arch Allergy Immunol; 2008; 146(1):66-70. PubMed ID: 18087163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.